A chronic hypercoagulable state in patients with β-thalassaemia major is already present in childhood

British Journal of Haematology

Volumn 107, Issue 4, 1999, Pages 739-746

  Eldor, A ^a   Durst, R ^b   Hy Am, E ^b   Goldfarb, A ^b   Gillis, S ^b   Rachmilewitz, E A ^b   Abramov, A ^c   Maclouf, J ^d   Godefray, Y C ^d   De Raucourt, E ^e   Guillin, M C ^e  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

^d HÔPITAL LARIBOISIÈRE   (France)

^e BEAUJON HOSPITAL   (France)

Author keywords

Protein C; Protein S; Thrombosis; Thromboxane A2; Thalassaemia

Indexed keywords

11 OXOTHROMBOXANE B2; ANTITHROMBIN III; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; MEMBRANE PHOSPHOLIPID; PHOSPHATIDYLSERINE; PLASMINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CHILD; CONTROLLED STUDY; ERYTHROCYTE DISORDER; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MUTATION; PRIORITY JOURNAL; THALASSEMIA MAJOR; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 0033396969     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01758.x     Document Type: Article

References (42)

1. Borenstain-Ben Yashar, V., Barenholtz, Y., Hy-Am, E., Rachmilewitz, E.A. & Eldor, A. (1993) Phosphatidylserine in the outer leaflet of red blood cells from β-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. American Journal of Hematology, 44, 63-65.
2. Borgna Pignatti, C., Carnellim, V., Caruso, V., Dore, F., De Mattia, D., Di Palma, A., Di Gregorio, F., Romeo, M.A., Longhi, R., Mangiagli, A., Melevendi C, Pizzarelli, G. & Musumeci, S. (1998a) Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematologica, 99, 76-79.
3. Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Piga, A., Di Gregorio, F., Gamberini, M.R., Sabato, V., Melevendi, C., Cappellini, M.D. & Verlato, G. (1998b) Survival and disease complications in thalassemia major. Annals of the New York Academy of Sciences, 850, 227-231.
4. Brenner, B., Zivelin, A., Lanir, N., Greengard, J.S., Griffin, J.H. & Seligsohn, U. (1996) Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis. Blood, 88, 877-880.
5. Cappellini, M.D., Coppola, R., Robbiolo, L., Graziadei, G., Valentini, M., Ariens, R.A.S., Fiorelli, G. & Mannucci, P.M. (1996) Procoagulant activity of erythrocytes in thalassemia intermedia. Blood, 88, (Suppl 1), 38a.
6. Chen, S., Eldor, A., Barshtein, G., Zhang, S., Goldfarb, A., Rachmilewitz, E. & Yedgar, S. (1996) Enhanced aggregability of red cells of thalassemia major patients. American Journal of Physiology, 270, H1951-H1956.
7. Cooper, D.M., Mansell, A.L. & Weiner, M.A. (1980) Low lung capacity and hypoxemia in children with thalassemia major. Annual Review of Respiratory Diseases, 121, 639-642.
8. Dahlback, B., Wiedmer, T. & Sims, P.J. (1992) Binding of anticoagulant vitamin K dependent protein S to platelet-derived microparticles. Biochemistry, 31, 12769-12775.
9. Davi, G., Catalano, I., Averna, M., Notarbartolo, A., Strano, A., Ciabattoni, G. & Patrono, C. (1990) Thromboxane biosynthesis and platelet function in type II diabetes mellitus. New England Journal of Medicine, 322, 1769-1774.
10. Del Principe, D., Menidhelli, A., Di Giulio, S., De Matteis, W., Cianciulli, P. & Papa. G. (1993) PADGEM/GMP-140 expression on platelet membrane from homozygous β-thalassaemia patients. British Journal of Haematology, 84, 111-117.
11. Eldor, A. (1978) Abnormal platelet function in β-thalassaemia. Scandinavian Journal of Haematology, 20, 447-452.
12. Eldor, A., Krausz, Y., Atlan, H., Snyder, D., Goldfarb, A., Hy-Am, E., Rachmilewitz, E.A., Kotze, H.F. & Heyns, A.P. (1989) Platelet survival in patients with β-thalassemia. American Journal of Hematology, 32, 94-99.
13. Eldor, A., Lellouche, F., Goldfarb, A., Rachmilewitz, E.A. & Maclouf, J. (1991) In-vivo platelet activation in β-thalassemia major reflected by increased platelet thromboxane-urinary-metabolites. Blood, 77, 1749-1753.
14. El Hazmi, M.A.E., Warsy, A.S. & Bahakim, H. (1993) Blood protein C and S sickle cell disease. Acta Haematologica, 90, 114-117.
15. Fitzgerald, D.J., Roy, L., Catella, F. & FitzGerald, G.A. (1986) Platelet activation in unstable coronary disease. New England Journal of Medicine, 315, 983.
16. FitzGerald, G.A., Smith, B., Pedersen, A.K. & Brash, A.R. (1984) Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. New England Journal of Medicine, 313, 1065-1069.
17. Francis, R.B. (1988) Protein S deficiency in sickle cell anemia. Journal of Laboratory and Clinical Medicine, 111, 571-575.
18. Frosst, P., Blom, H.J. & Milos, R. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylene-tetrahydrofolate reductase. Nature Genetics, 10, 111-113.
19. Grant, G.P., Mansell, A.L., Graziano, J.H. & Mellins, R.B. (1986) The effect of transfusion on lung capacity, diffusing capacity and material oxygen saturation in patients with β-thalassemia major. Pediatric Research, 20, 20-29.
20. Grisaru, D., Rachmilewitz, E.A., Mosseri, M., Gotsman, M., Lafair, J., Okun, E., Goldfarb, A. & Hasin, Y. (1990) Cardiopulmonary assessment in β-thalassemia major, Chest, 98, 1138-1142.
21. Helley, D., Eldor, A., Girot, R., Ducrocq, R., Guillin, M.C. & Bezeaud, A. (1996) Comparison of the procoagulant activity of red blood cells from patients with homozygous sickle cell disease and β-thalassemia. Thrombosis and Haemostasis, 76, 322-327.
22. Kuypers, F.A., Yuan, J., Lewis, R.A., Snyder, M., Kiefer, C.R., Bunyaratvej, A., Fucharoen, S., Ma, L., Styles, L., de Jong, K. & Schrier, L.S. (1998) Membrane phospholipid asymmetry in human thalassemia. Blood, 91, 3044-3048.
23. Karayaclin, G. & Lanzowsky, P. (1989) Plasma protein C levels in children with sickle cell disease. American Journal of Pediatric Hematology and Oncology, 11, 320-325.
24. Lane, P.A., O'Connell, J.L. & Marler, R.A. (1994) Erythrocyte membrane vesicles and irreversibly sickled cells bind protein S. American Journal of Hematology, 47, 295-300.
25. Logothetis, J., Consantoulakis, M., Economidou, J., Stefanis, C., Hakas, P., Angoustaki, O., Sofraniadou, K., Loewenson, R. & Bilek, M.S. (1972) Thalassemia major (homozygous β-thalassemia): a survey of 138 cases with emphasis on eurologic and muscular aspects. Neurology, 22, 294-304.
26. Michaeli, J., Mittelman, M., Grisaru, D. & Rachmilewitz, A.E. (1992) Thromboembolic complications in β-thalassemia major. Acta Haematologica, 87, 71-74.
27. Middelkoop, E., Lubin, B.H., Bevers, E.M., Op Den Kamp, J.A.F. Comfurius, P., Chiu, D.T.Y., Zwaal, R.F.A., Van Deenen, L.L.M. & Roelofsen, B. (1988) Studies on sickled erythrocytes provide evidence that the asymetric distribution of phosphatidylserine in the red cell membrane is maintained by both ATP-dependent translocation and interaction with membrane skeletal proteins. Biochimica et Biophysica Acta, 937, 281-288.
28. Moratelli, S., De Sanctis, V., Gemmati, D., Serino, M.L., Mari, R., Gamberini, M.R. & Scapoli, G.L. (1998) Thrombotic risk in thalassemic patients. Journal of Pediatric Endocrinology and Metabolism, 11, 915-921.
29. Musumeci, S., Leonardi, S., Di Dio, R., Fischer, A. & Di Costa, G. (1987) Protein C and antithrombin III in polytransfused thalassemic patients. Acta Haematologica, 77, 30-33.
30. 2 formation. New England Journal of Medicine, 319, 689-694.
31. Paolini, E., Monetti, V.C., Gronieri, E. & Boldrini, P. (1983) Acute cerebrovascular insults in homozygous β-thalassemia: a case report. Journal of Neurology, 230, 37-41.
32. Peters, M., Plaat, B.E.C., Ten Cate, H., Wolters, H.J., Weening, R.S. & Brandjes, D.P.M. (1994) Enhanced thrombin generation in children with sickle cell diseases. Thrombosis and Haemostasis, 71, 169-172.
33. Poort, S.R., Rosendaal, F.R., Reitsma, P.H. & Bertina, M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698-3703.
34. Ruf, A., Pick, M., Deutsch, V., Patscheke, H., Goldfarb, A. Rachmilewitz, E.A., Guillin, M.C. & Eldor, A. (1997) In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with β-thalassaemia major. British Journal of Haematology, 98, 51-59.
35. Shattil, S.J., Cunningham, M. & Hoxie, J.A. (1987) Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood, 70, 307-315.
36. Sinniah, D., Vignaendra, V. & Kamaruddin, A. (1972) Neurological complications of β-thalassemia major. Archives of Diseases of Children, 52, 977-979.
37. Sonakul, D. & Fucharoen, S. (1992) Pulmonary thromboembolism in thalassemic patients. Southeast Asian Journal of Tropical Medicine and Public Health, 23, (Suppl. 22), 25-28.
38. Sonakul, D., Pacharee, P., Laohapand, T., Fucharoen, S. & Wasi, P. (1990) Pulmonary artery obstruction in thalassemia. Southeast Asian Journal of Tropical Medicine and Public Health, 11, 516-523.
39. Sumiyoshi, A., Thakerngpol, K. & Sonakul, D. (1992) Pulmonary microthromboemboli in thalassemic cases. Southeast Asian Journal of Tropical Medicine and Public Health, 23, (Suppl. 22), 29-31.
40. Visudhiphan, S., Ketsa-Ard, K., Tumliang, S. & Piankijagum, A. (1994) Significance of blood coagulation and platelet profiles in relation to pulmonary thrombosis in beta-thalassemia/Hb E. Southeast Asian Journal of Tropical Medicine and Public Health, 25, 449-456.
41. Wong, V. Yu, Y.L., Liany, R.S.H., Tso, W.K., Li, A.M.C. & Chan, T.K. (1990) Cerebral thrombosis in β-thalassemia/hemoglobin H disease. Stroke, 21, 812-816.
42. Wright, J.G., Malia, R.G., Cooper, P., Thomas, P., Preston, E.E. & Serjeant, G.R. (1997) Protein C and protein S in homozygous sickle cell disease: does hepatic dysfunction contribute to low levels? British Journal of Haematology, 98, 627-630.